SC 13G

Company

Celldex Therapeutics, Inc.

Filed

February 14, 2002

Accession Number

0000908645-02-000031

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →